Company Overview and News

147
Apple Says It Wasn't About Money After Samsung Loses Patent Bet - Bloomberg

2018-05-25 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
U.S. jury awards Apple $539 million in Samsung patent retrial

2018-05-25 reuters
(Reuters) - After nearly five days of deliberations, a U.S. jury on Thursday said Samsung Electronics Co Ltd should pay $539 million to Apple Inc for copying patented smartphone features, according to court documents, bringing a years-long feud between the technology companies into its final stages.

 
South Korean stocks ETF tumbles after Trump cancels meeting with North Korea's Kim Jong Un

2018-05-25 cnbc
An exchange-traded fund tracking South Korean stocks briefly dropped more than 2.5 percent Thursday after President Donald Trump called off a nuclear summit with North Korea's Kim Jong Un.

 
With the Arrival of 5G, Apple Inc. Stock Can Far Surpass a $1-Trillion Market Cap

2018-05-25 investorplace
Apple Inc. (NASDAQ:AAPL) finds itself at a crossroads. Hardware sales have slowed down, and new products have failed to match the sales numbers of the iPhone. However, the adoption of 5G technology will likely drive customers to buy new iPhones and other products. Given the coming arrival of 5G, investors should look well beyond the near arrival of the $1-trillion market cap.

 
Synopsys' (SNPS) Q2 Earnings Match Estimates, Revenues Beat

2018-05-25 zacks
Synopsys Inc. (SNPS - Free Report) reported second-quarter fiscal 2018 results, wherein the bottom line came in line with the Zacks Consensus Estimate while revenues beat the same. The results also marked year-over-year improvement. The company reported non-GAAP earnings per share of $1.08, which came in 22.7% higher than the year-ago quarter’s non-GAAP earnings of 88 cents. Quarter in Detail The company’s fiscal second-quarter revenues jumped 14.

 
US jury awards Apple US$539 million in Samsung patent retrial

2018-05-25 channelnewsasia
REUTERS: After nearly five days of deliberations, a U.S. jury on Thursday said Samsung Electronics Co Ltd should pay US$539 million to Apple Inc for copying patented smartphone features, according to court documents, bringing a years-long feud between the technology companies into its final stages.

 
Apple partner TSMC is said to start making chips for new iPhones

2018-05-23 scmp
The next generation chips will be faster and more efficient than those used in current iPhone 8 and iPhone X

 
The party may have ended for Vietnamese large caps, but there’s value to be found in small stocks

2018-05-23 scmp
Some fund managers are still optimistic about returns from Vietnamese equities even after the market has cooled somewhat from its heady days in 2017

 
How to Turn Your Mom’s Savings Into $1 Billion? Ask This Guy - Bloomberg

2018-05-22 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Clark airport O&M attracts interest

2018-05-22 bworldonline
A CONTRACT to operate and maintain (O&M) for 25 years an expanded Clark International Airport — designed to decongest the premier gateway in Metro Manila — has attracted several groups that sent representatives to a pre-bid conference in Bonifacio Global City, Taguig City on Monday.

1
Sony invests in image sensors, acquires more of EMI Music

2018-05-22 technology.inquirer.net
Sony Corp. President Kenichiro Yoshida speaks as characters from Peanuts are shown at a press conference at the company’s headquarters Tuesday, May 22, 2018, in Tokyo. (AP)

 
The lucky 56: Xiaomi IPO to make dozens of workers millionaires

2018-05-22 scmp
The employees stake in the company may soon be worth US$1 billion to US$3 billion, depending on the stock sale. That works out to $36 million each at the midpoint

 
SNE Stock: Sony Corp (ADR) Is This Decade’s Underappreciated Turnaround | InvestorPlace

2018-05-21 investorplace
Among the so-called recovery stories, Sony Corp (ADR) (NYSE:SNE) is one of the more intriguing, and frustrating. Last year, SNE stock turned in a massive performance, delivering 60% returns to long-embattled shareholders. This followed a fairly solid 15% haul in 2016.

 
Amazon helps Shenzhen entrepreneur turn mom’s money into a billion dollars

2018-05-21 japantimes.co.jp
HONG KONG – After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture capital money to fund his business idea.

 
Amazon helps ex-Googler turn mom’s money into a billion dollars

2018-05-21 livemint
Hong Kong: After Steven Yang left his coveted job at Google, he asked his mother whether he should take venture-capital money to fund his business idea.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...